8E1G
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 8e1g by Molmil](/molmil-images/mine/8e1g) | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2A10 Fab, heavy chain, ... | 著者 | Wasserman, H, Hastie, K.M, Buck, T.K, Saphire, E.O. | 登録日 | 2022-08-10 | 公開日 | 2023-06-28 | 最終更新日 | 2023-10-25 | 実験手法 | X-RAY DIFFRACTION (2.57 Å) | 主引用文献 | Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep, 42, 2023
|
|
7K5L
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 7k5l by Molmil](/molmil-images/mine/7k5l) | Ebola virus VP40 octameric ring generated by an RNA oligonucleotide | 分子名称: | HSP RNA oligonucleotide, Matrix protein VP40 | 著者 | Landeras-Bueno, S, Wasserman, H, Salie, Z.L, Saphire, E.O. | 登録日 | 2020-09-17 | 公開日 | 2021-04-21 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (1.38 Å) | 主引用文献 | Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form. Cell Rep, 35, 2021
|
|
7K5D
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 7k5d by Molmil](/molmil-images/mine/7k5d) | Ebola virus VP40 octameric ring generated by a DNA oligonucleotide | 分子名称: | HSP DNA oligonucleotide, Matrix protein VP40 | 著者 | Landeras-Bueno, S, Wasserman, H, Salie, Z.L, Saphire, E.O. | 登録日 | 2020-09-16 | 公開日 | 2021-04-21 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (1.78 Å) | 主引用文献 | Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form. Cell Rep, 35, 2021
|
|
8F0G
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 8f0g by Molmil](/molmil-images/mine/8f0g) | Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Antibody 1C3 Fab Heavy Chain, ... | 著者 | Yu, X, Zyla, D, Hastie, K.M, Saphire, E.O. | 登録日 | 2022-11-02 | 公開日 | 2023-05-03 | 実験手法 | ELECTRON MICROSCOPY (3.35 Å) | 主引用文献 | Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep, 42, 2023
|
|
8F0H
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 8f0h by Molmil](/molmil-images/mine/8f0h) | Structure of SARS-CoV-2 spike with antibody Fabs 2A10 and 1H2 (Local refinement of the RBD and Fabs 1H2 and 2A10) | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, Antibody Fab 1H2 heavy chain, Antibody Fab 1H2 light chain, ... | 著者 | Yu, X, Zyla, D, Hastie, K.M, Saphire, E.O. | 登録日 | 2022-11-02 | 公開日 | 2023-05-03 | 実験手法 | ELECTRON MICROSCOPY (3.18 Å) | 主引用文献 | Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep, 42, 2023
|
|